Barrier isolators as an alternative to a cleanroom

American Journal of Health-System Pharmacy

Volumn 56, Issue 14, 1999, Pages 1433-1436

  Tillett, Lance ^a  

^a Saint Joseph's Hospital of Atlanta   (United States)

Author keywords

Antineoplastic agents; Aseptic areas; Compounding; Economics; Equipment; Hazardous substances; Toxicity, environmental

Indexed keywords

ACRYLIC ACID; CYTOTOXIC AGENT; EPOXIDE; POLYCARBONATE; STEEL;

ARTICLE; CLEANING; CONTAMINATION; COST EFFECTIVENESS ANALYSIS; DANGEROUS GOODS; ISOLATION PROCEDURE; MATERIALS HANDLING; PRIORITY JOURNAL; PROTECTIVE CLOTHING; SAFETY;

EID: 0033565787     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/56.14.1433     Document Type: Article

References (5)

1. ASHP technical assistance bulletin on quality assurance for pharmacy-prepared sterile products [resource on World Wide Web]. URL: http://www.ashp.org. American Society of Hospital Pharmacists. Available from Internet. Accessed 1998 Jun 9.
2. Oles P, St. Martin B, Teillon J et al. Isolator technology for manufacturing and quality control. Aseptic pharmaceutical manufacturing: technology for the 1990s. Prairie View, IL: Interpharm; 1987:219-45.
3. Federal Standard No. 209E. Airborne particulate cleanliness classes in cleanrooms and clean zones. Washington, DC: General Services Administration; 1992.
4. ASHP technical assistance bulletin on quality assurance for pharmacy-prepared sterile products [resource on World Wide Web]. URL: http://www.ashp.org. American Society of Hospital Pharmacists. Available from Internet. Accessed 1998 Jun 9.
5. Clark RP, Goff MR. The potassium iodide method for determining protection factors in open-fronted microbiological safety cabinets. J Appl Biol. 1981; 51:461-73.